Rationale, Data, and Future of Using Ide-Cel CAR T-Cell Therapy
September 1st 2021Larry D. Anderson, Jr, MD, PhD, discusses the rationale behind using chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma, data from the KarMMa trial, and other trials investigating this treatment.
Watch
EP. 1A: The Role of Imaging and Genomic Testing in Prostate Cancer Treatment
August 30th 2021In this first video of the series, Neeraj Agarwal, MD, of the Huntsman Cancer Institute of the University of Utah explains the role of imaging and genomic testing in the diagnosis and treatment of prostate cancer.
Watch